Evidence map›Paper›PMID 29781959›Full record

ArticlePain2018

Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity.

Alexander G J Skorput, Xijing Zhang, Jonathan J Waataja, Cristina D Peterson, Maureen S Riedl, Kelley F Kitto, Hai Truong, Cecilia Huffman, Stephen R Salton, Carolyn A Fairbanks and 2 more

Abstract read
In one paragraph

Article in Pain, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neural regeneration research · 2024
    Review
  6. Thalamocortical axons regulate neurogenesis and laminar fates in the early sensory cortex.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Alexander G J SkorputDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Xijing ZhangDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Jonathan J WaatajaDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Cristina D PetersonGraduate Program in Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, United States.
Maureen S RiedlDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Kelley F KittoDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Hai TruongDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Cecilia HuffmanDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Stephen R SaltonDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Carolyn A FairbanksDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Christopher N HondaDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
Lucy VulchanovaDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
University of Minnesota · USIcahn School of Medicine at Mount Sinai · US

Funding

Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
VGF, critical role in the transition from acute to chronic painR01DE021996 · NIDCR · UNIVERSITY OF MINNESOTA · PI SALTON, STEPHEN R, VULCHANOVA, LYUDMILA H · 2011 to 2015
$2.4M
TLQP-21 and C3aR, a Novel Receptor/Ligand Interaction in Neuropathic PainR01NS088518 · NINDS · UNIVERSITY OF MINNESOTA · PI VULCHANOVA, LYUDMILA H · 2014 to 2018
$1.7M
Function of the VGF-derived neuropeptide TLQP-62 in gating tactile allodyniaF32NS100438 · NINDS · UNIVERSITY OF MINNESOTA · PI SKORPUT, ALEXANDER · 2017 to 2018
$96k
NIDA NIH HHS T32 DA007097NIDCR NIH HHS R01 DE021996NINDS NIH HHS F32 NS100438NINDS NIH HHS R01 NS088518
6 · The paper itself

Abstract

Neuroplasticity in the dorsal horn after peripheral nerve damage contributes critically to the establishment of chronic pain. The neurosecretory protein VGF (nonacronymic) is rapidly and robustly upregulated after nerve injury, and therefore, peptides generated from it are positioned to serve as signals for peripheral damage. The goal of this project was to understand the spinal modulatory effects of the C-terminal VGF-derived peptide TLQP-62 at the cellular level and gain insight into the function of the peptide in the development of neuropathic pain. In a rodent model of neuropathic pain, we demonstrate that endogenous levels of TLQP-62 increased in the spinal cord, and its immunoneutralization led to prolonged attenuation of the development of nerve injury-induced hypersensitivity. Using multiphoton imaging of submaximal glutamate-induced Ca responses in spinal cord slices, we demonstrate the ability of TLQP-62 to potentiate glutamatergic responses in the dorsal horn. We further demonstrate that the peptide selectively potentiates responses of high-threshold spinal neurons to mechanical stimuli in singe-unit in vivo recordings. These findings are consistent with a function of TLQP-62 in spinal plasticity that may contribute to central sensitization after nerve damage.

Indexed as

AnimalsCalciumHyperalgesiaMaleMiceNeuronal PlasticityNeuronsNeuropeptidesPain MeasurementPeptidesPeripheral Nerve InjuriesRatsRats, Sprague-DawleySpinal CordCalciumNeuropeptidesPeptidesTLQP62 peptideVGF peptide

Identifiers

PMID29781959
PMCPMC6095807
OpenAlexW2803297920

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.